Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

Pegs, I'm no expert in FDA clinical trials, but there is the likelihood that the NIH did not construct the trials in the best way they could/should have. Example: I'm hearing/reading that Remdes was given for 10 days, while aviptadil only 3 days. We just aren't privy to all of the facts and information.

Having said that, the FDA is the Gold Standard. Even if they screwed up in approving the design of the NIH trial, it is what it is. The world takes notice to FDA decisions, and we know that the FDA listens to the NIH.

IMO NRXP is burned toast, but RLFTF still has other meds in the pipeline. So long as the ADR conversion process doesn't burn the SH, there is still hope for RLFTF. Now we are clinging to straws though. If ACER does not receive FDA approval for ACER-001 on June 5, 2022, then I think it is all over for RLFTF incumbent investors who have been trying to get back to break even. JMHO. The wise investors diversified and did not put all of their eggs in one basket.